McKesson Corporation $MCK Holdings Lifted by Titan Investment Management LLC

Titan Investment Management LLC lifted its stake in shares of McKesson Corporation (NYSE:MCK) by 20.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,711 shares of the company’s stock after acquiring an additional 622 shares during the period. McKesson makes up about 2.4% of Titan Investment Management LLC’s investment portfolio, making the stock its 12th largest holding. Titan Investment Management LLC’s holdings in McKesson were worth $3,168,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently made changes to their positions in MCK. Curry Webb Wealth Management LLC acquired a new position in McKesson in the 3rd quarter worth $38,000. Brookstone Capital Management increased its holdings in McKesson by 15.9% during the 3rd quarter. Brookstone Capital Management now owns 20,026 shares of the company’s stock worth $17,098,000 after purchasing an additional 2,754 shares in the last quarter. Virtue Asset Management LLC raised its stake in shares of McKesson by 2.9% in the 3rd quarter. Virtue Asset Management LLC now owns 3,938 shares of the company’s stock valued at $3,362,000 after purchasing an additional 111 shares during the period. NBT Bank N.A. acquired a new stake in shares of McKesson in the 3rd quarter valued at about $308,000. Finally, Isthmus Partners LLC raised its stake in shares of McKesson by 14.5% in the 3rd quarter. Isthmus Partners LLC now owns 1,105 shares of the company’s stock valued at $943,000 after purchasing an additional 140 shares during the period. Institutional investors own 85.07% of the company’s stock.

Insider Transactions at McKesson

In other McKesson news, EVP Francisco Fraga sold 800 shares of McKesson stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $995.80, for a total transaction of $796,640.00. Following the completion of the transaction, the executive vice president directly owned 5,423 shares of the company’s stock, valued at $5,400,223.40. The trade was a 12.86% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Napoleon B. Rutledge, Jr. sold 111 shares of McKesson stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $891.45, for a total transaction of $98,950.95. Following the sale, the chief accounting officer directly owned 521 shares of the company’s stock, valued at $464,445.45. The trade was a 17.56% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,212 shares of company stock worth $1,164,182 in the last ninety days. Insiders own 0.06% of the company’s stock.

Key Stories Impacting McKesson

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: Mizuho raised its price target for McKesson to $1,020, implying modest additional upside from recent trading levels. The upgrade follows the stock reaching a new one-year high and could support investor confidence. Mizuho raises McKesson price target
• Positive Sentiment: A recent analysis argues that artificial-intelligence initiatives and a potential FDA overhaul could become larger growth drivers for McKesson in 2027, potentially outweighing current regulatory headwinds. McKesson AI and FDA outlook
• Neutral Sentiment: McKesson declared a quarterly dividend of $0.94 per share, payable January 4, 2027, to shareholders of record December 1. The annualized payout is $3.76, representing a relatively low yield of about 0.4%, so the announcement is primarily a signal of continued shareholder returns rather than a major income catalyst. McKesson declares quarterly dividend
• Neutral Sentiment: Investor attention remains elevated after McKesson’s strong long-term performance and recent analyst upgrade, but elevated valuation and the stock’s proximity to its 52-week high may limit near-term upside. McKesson reaches one-year high
• Negative Sentiment: An insider, Francisco Fraga, reportedly sold 800 McKesson shares. The transaction is not necessarily a fundamental warning, but insider selling can weigh modestly on sentiment. McKesson insider share sale
• Negative Sentiment: Coverage of a McKesson-related security incident highlights potential cybersecurity and operational risks, which could add to investor concerns alongside regulatory uncertainty. McKesson security incident analysis

McKesson Trading Down 0.5%

Shares of MCK stock opened at $1,010.85 on Friday. McKesson Corporation has a 1 year low of $723.68 and a 1 year high of $1,030.27. The firm’s fifty day moving average price is $908.70 and its two-hundred day moving average price is $841.27. The firm has a market capitalization of $117.86 billion, a P/E ratio of 27.05, a PEG ratio of 2.02 and a beta of 0.30.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $9.93 EPS for the quarter, topping the consensus estimate of $9.56 by $0.37. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. The firm had revenue of $105.38 billion for the quarter, compared to analysts’ expectations of $103.88 billion. During the same period in the previous year, the firm posted $8.26 EPS. The company’s revenue for the quarter was up 7.7% on a year-over-year basis. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. As a group, equities research analysts forecast that McKesson Corporation will post 44.71 EPS for the current fiscal year.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Tuesday, December 1st will be issued a dividend of $0.94 per share. This represents a $3.76 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Tuesday, December 1st. McKesson’s payout ratio is presently 10.06%.

Analyst Ratings Changes

A number of brokerages have recently commented on MCK. UBS Group boosted their price target on McKesson from $1,080.00 to $1,200.00 and gave the company a “buy” rating in a report on Friday, October 16th. Bank of America increased their price objective on McKesson from $950.00 to $1,050.00 in a report on Thursday, August 6th. Mizuho boosted their target price on McKesson from $905.00 to $1,020.00 and gave the company a “neutral” rating in a research note on Tuesday. Morgan Stanley set a $977.00 target price on McKesson in a research note on Tuesday, October 6th. Finally, Leerink Partners upped their price target on McKesson from $1,030.00 to $1,070.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 7th. Fifteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, McKesson has an average rating of “Moderate Buy” and an average price target of $997.12.

McKesson Profile

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and medical products to pharmacies, hospitals, health systems, physicians and other healthcare providers. The company also provides technology, data and business solutions designed to support prescription management, pharmacy operations and patient care.

McKesson’s principal activities include pharmaceutical distribution, medical-surgical supply distribution, specialty pharmaceutical services and oncology care support.